scholarly journals Novel Oral P2Y12 Inhibitor Prasugrel vs. Clopidogrel in Patients with Acute Coronary Syndrome: Evidence Based on 6 Studies

2015 ◽  
Vol 21 ◽  
pp. 1131-1137 ◽  
Author(s):  
Keyong Chen
Keyword(s):  
Acute Coronary Syndrome ◽  
Evidence Based ◽  
P2y12 Inhibitor ◽  
Coronary Syndrome

scholarly journals CV2 Age, Dementia, and Evidence-Based Medication Use After Admission for Acute Coronary Syndrome

2012 ◽  
Vol 15 (7) ◽  
pp. A607
Author(s):  
C.F. Lin ◽  
F.Y. Hsiao ◽  
F.L.L. Wu ◽  
C.H. Bai ◽  
C.S. Gau ◽  
...  
Keyword(s):  
Acute Coronary Syndrome ◽  
Medication Use ◽  
Evidence Based ◽  
Coronary Syndrome

Risk of cancer after an acute coronary syndrome according to the type of P2Y12 inhibitor

2019 ◽  
Vol 174 ◽  
pp. 51-58 ◽  
Author(s):  
Sergio Raposeiras-Roubín ◽  
Emad Abu-Assi ◽  
Isabel Muñoz-Pousa ◽  
María Cespón-Fernández ◽  
Rafael Cobas-Paz ◽  
...  
Keyword(s):  
Acute Coronary Syndrome ◽  
P2y12 Inhibitor ◽  
Coronary Syndrome ◽  
Risk Of Cancer

scholarly journals Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndrome

2020 ◽  
Vol 9 (7) ◽  
pp. 2020
Author(s):  
Wilbert Bor ◽  
Diana A. Gorog
Keyword(s):  
Atrial Fibrillation ◽  
Acute Coronary Syndrome ◽  
Combination Therapy ◽  
Bleeding Risk ◽  
Careful Consideration ◽  
P2y12 Inhibitor ◽  
Coronary Syndrome ◽  
Antithrombotic Efficacy ◽  
Selection Of ◽  
Made In

Acute coronary syndrome and atrial fibrillation are both common and can occur in the same patient. Combination therapy with dual antiplatelet therapy and oral anticoagulation increases risk of bleeding. Where the two conditions coexist, careful consideration is needed to determine the optimal antithrombotic treatment to reduce the risks of future ischaemic events associated with both conditions. Choices can be made in intraprocedural anticoagulation, type and dosing of oral anticoagulant, duration of combination therapy, and selection of P2Y12 inhibitor including genetic testing. This review article provides an overview of the available evidence to support clinicians in finding the delicate balance between antithrombotic efficacy and bleeding risk in patients with acute coronary syndrome and atrial fibrillation.

Utilization of Evidence-Based Therapy for Acute Coronary Syndrome in High Income and Middle/Low Income Countries

2013 ◽  
Vol 29 (10) ◽  
pp. S297-S298
Author(s):  
A. Shimony ◽  
S.M. Grandi ◽  
L. Pilote ◽  
L. Joseph ◽  
J. O'Loughlin ◽  
...  
Keyword(s):  
Acute Coronary Syndrome ◽  
Low Income ◽  
High Income ◽  
Low Income Countries ◽  
Evidence Based ◽  
Coronary Syndrome ◽  
Evidence Based Therapy
Sign in / Sign up

Export Citation Format

Share Document